Torrent Pharmaceuticals company profile
Company profile
Torrent Pharmaceuticals has 18,258 employees and is headquartered in Ahmedabad, India.
Shelcal, Tedibar, Unienzyme, ProZuca and Ahaglow are among the brands under which the company sells its products. Torrent Pharmaceuticals develops, makes, markets and distributes branded and generic medicines, along with vitamin, mineral and nutrient supplements. Its range spans diabetes, cardiovascular care, the central nervous system, oncology, gastrointestinal, urology and dermatology treatments, among others. The company also offers contract manufacturing services and sells in India, the United States, Brazil, Germany, Malta and other international markets.
In the fiscal year ended March 2026, Torrent Pharmaceuticals reported revenue of INR 139.8 billion, up 21.4% from the previous year, and net profit of INR 21.6 billion. The company employed 18,258 people. It was founded in 1959 and is headquartered in Ahmedabad, India. Its shares also trade on the BSE.
Company facts
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Country
- India
- Headquarters
- Avirat, Thaltej Shilaj Road, 380059, Ahmedabad
- Employees
- 18,258
- Chief executive
- Aman Mehta
- Founded
- 1959
- Fiscal year
- April - March
- Listing
- TORNTPHARM · NSE
- Currency
- INR
- ISIN
- INE685A01028
- Website
- torrentpharma.com
Torrent Pharmaceuticals and its competitors
The most similar companies by business and size
| Company | Country | Market cap | Employees | Operating margin | P/E (trailing 12 months) |
|---|---|---|---|---|---|
| Torrent PharmaceuticalsTORNTPHARM | India | $19.25B | 18,258 | 22.2% | 79.2 |
| Shionogi4507 | Japan | $16.75B | 6,223 | 31.6% | 11.2 |
| PharmaEssentia6446 | Taiwan | $15.94B | 131 | 38.4% | 74.1 |
| Hansoh Pharmaceutical Group3692 | Hong Kong SAR China | $23.77B | 9,643 | 37.3% | 25.0 |
| Yunnan Baiyao Group000538 | China | $15.07B | 9,286 | 11.2% | 19.4 |
| Laurus LabsLAURUSLABS | India | $14.13B | 7,059 | 24.1% | 97.8 |
Competitors: same or related industry, same region first, then the closest market capitalization. Market cap converted into US dollars at the latest exchange rates; P/E over the last 12 months, not shown when negative.
